Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

Antonino Buffon, A Lupi, Ep Navarese, M Lazzero, M Sansa, S De Servi, A Serra, As Bongo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

17 Citazioni (Scopus)

Abstract

Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.
Lingua originaleEnglish
pagine (da-a)280-289
Numero di pagine10
RivistaCirculation Journal
Volume75
Stato di pubblicazionePubblicato - 2011

Keywords

  • Aged
  • Aged, 80 and over
  • Angioplasty
  • Bias (Epidemiology)
  • Clinical Trials as Topic
  • Coronary Artery Bypass
  • Coronary Disease
  • Coronary Restenosis
  • Diabetic Angiopathies
  • Drug-Eluting Stents
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Odds Ratio
  • Paclitaxel
  • Postoperative Complications
  • Randomized Controlled Trials as Topic
  • Regression Analysis
  • Saphenous Vein
  • Sirolimus
  • Stents
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients'. Insieme formano una fingerprint unica.

Cita questo